Joshua A Kazam - Net Worth and Insider Trading
Joshua A Kazam Net Worth
The estimated net worth of Joshua A Kazam is at least $833,533 dollars as of 2024-11-13. Joshua A Kazam is the Director of Allogene Therapeutics Inc and owns about 258,885 shares of Allogene Therapeutics Inc (ALLO) stock worth over $735,233. Joshua A Kazam is also the Director of Target Hospitality Corp and owns about 10,000 shares of Target Hospitality Corp (TH) stock worth over $98,300. Details can be seen in Joshua A Kazam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua A Kazam has not made any transactions after 2022-01-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joshua A Kazam
Joshua A Kazam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua A Kazam owns 17 companies in total, including Kronos Bio Inc (KRON) , Allogene Therapeutics Inc (ALLO) , and Flying Eagle Acquisition Corp (FEAC.U) among others .
Click here to see the complete history of Joshua A Kazam’s form 4 insider trades.
Insider Ownership Summary of Joshua A Kazam
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRON | Kronos Bio Inc | 2020-10-08 | director |
ALLO | Allogene Therapeutics Inc | 2022-01-12 | director |
FEAC.U | Flying Eagle Acquisition Corp | 2020-03-05 | director |
2019-12-31 | director | ||
2019-03-05 | director | ||
2009-07-07 | director | ||
2017-09-28 | director | ||
2008-06-03 | director | ||
2004-01-28 | director | ||
2019-03-05 | director | ||
2020-03-05 | director | ||
2020-11-09 | director | ||
2021-02-23 | director | ||
2021-02-11 | director | ||
2022-01-05 | director | ||
2021-02-11 | director | ||
2020-11-09 | director |
Joshua A Kazam Latest Holdings Summary
Joshua A Kazam currently owns a total of 2 stocks. Among these stocks, Joshua A Kazam owns 258,885 shares of Allogene Therapeutics Inc (ALLO) as of January 12, 2022, with a value of $735,233 and a weighting of 88.21%. Joshua A Kazam also owns 10,000 shares of Target Hospitality Corp (TH) as of March 5, 2019, with a value of $98,300 and a weighting of 11.79%.
Latest Holdings of Joshua A Kazam
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ALLO | Allogene Therapeutics Inc | 2022-01-12 | 258,885 | 2.84 | 735,233 |
TH | Target Hospitality Corp | 2019-03-05 | 10,000 | 9.83 | 98,300 |
Holding Weightings of Joshua A Kazam
Joshua A Kazam Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua A Kazam has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Allogene Therapeutics Inc is the acquisition of 15,000 shares on January 12, 2022, which cost Joshua A Kazam around $189,000.
According to the SEC Form 4 filings, Joshua A Kazam has made a total of 0 transactions in Target Hospitality Corp (TH) over the past 5 years. The most-recent trade in Target Hospitality Corp is the acquisition of 5,000 shares on March 5, 2019, which cost Joshua A Kazam around $51,000.
Insider Trading History of Joshua A Kazam
- 1
Joshua A Kazam Trading Performance
GuruFocus tracks the stock performance after each of Joshua A Kazam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua A Kazam is -11.17%. GuruFocus also compares Joshua A Kazam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua A Kazam within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua A Kazam's insider trading performs compared to the benchmark.
Performance of Joshua A Kazam
Joshua A Kazam Ownership Network
Ownership Network List of Joshua A Kazam
Ownership Network Relation of Joshua A Kazam
Joshua A Kazam Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Joshua A Kazam is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Joshua A Kazam made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Joshua A Kazam Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua A Kazam. You might contact Joshua A Kazam via mailing address: 689 5th Avenue, 12th Floor, New York Ny 10022.